FDA Import Refusal 799-6155801-2/11/1 — Eris Lifesciences
The FDA refused shipment 799-6155801-2/11/1 from Eris Lifesciences (India) on Jul 21, 2023. The refused product falls under Drugs and Biologics — DAPAGLIFLOZIN (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Jul 21, 2023
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PDA70 DAPAGLIFLOZIN (ANTI-DIABETIC)
- Charges
- 75